These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37109685)

  • 1. The Length of Hospital Stay of Patients with Venous Thromboembolism: A Cross-Sectional Study from Jordan.
    Amawi H; Arabyat RM; Al-Azzam S; AlZu'bi T; U'wais HT; Hammad AM; Amawi R; Nusair MB
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109685
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
    Lee Y; Jehangir Q; Li P; Gudimella D; Mahale P; Lin CH; Apala DR; Krishnamoorthy G; Halabi AR; Patel K; Poisson L; Balijepally V; Sule AA; Nair GB
    BMC Infect Dis; 2022 May; 22(1):462. PubMed ID: 35562677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
    Goldhaber SZ; Ageno W; Casella IB; Chee KH; Schellong S; Singer DE; Desch M; Reilly PA; Donado E; Tang W; Voccia I; Schulman S
    Am J Med; 2020 Aug; 133(8):936-945. PubMed ID: 32325043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials.
    Hong Y; Mansour S; Alotaibi G; Wu C; McMurtry MS
    Crit Rev Oncol Hematol; 2018 May; 125():12-18. PubMed ID: 29650271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in the Practice Pattern for Venous Thromboembolism in Japan: Insight From JROAD-DPC.
    Yamashita Y; Morimoto T; Yoshikawa Y; Yaku H; Sumita Y; Nakai M; Ono K; Kimura T
    J Am Heart Assoc; 2020 Jan; 9(2):e014582. PubMed ID: 31918600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
    Huang W; Goldberg RJ; Cohen AT; Anderson FA; Kiefe CI; Gore JM; Spencer FA
    Thromb Res; 2015 Jun; 135(6):1100-6. PubMed ID: 25921936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.
    Cohen AT; Gitt AK; Bauersachs R; Fronk EM; Laeis P; Mismetti P; Monreal M; Willich SN; Bramlage P; Agnelli G; Prefer In Vte Scientific Steering Committee And The Prefer In Vte Investigators OBOT
    Thromb Haemost; 2017 Jun; 117(7):1326-1337. PubMed ID: 28405675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receipt of anticoagulation after venous thromboembolism diagnoses during delivery hospitalizations.
    O'Shaugnessy F; Syeda SK; Huang Y; D'Alton ME; Wen T; Wright JD; Friedman AM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6353-6355. PubMed ID: 33855935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.
    Bookhart BK; Haskell L; Bamber L; Wang M; Schein J; Mody SH
    J Med Econ; 2014 Oct; 17(10):691-5. PubMed ID: 25065536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Hospital Length of Stay among VTE Cases: Insights from the i-RegVed Registry.
    Aggarwal S; Rulu P; ; Tabassum H
    J Prim Care Community Health; 2024; 15():21501319241266815. PubMed ID: 39118386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
    Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
    Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.
    Liu X; Johnson M; Mardekian J; Phatak H; Thompson J; Cohen AT
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26627879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
    Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program.
    Matsuo H; Prins M; Lensing AW; Fujinuma EW; Miyamoto Y; Kajikawa M
    Curr Med Res Opin; 2015 Jun; 31(6):1057-61. PubMed ID: 25851062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inpatient versus post-discharge venous thromboembolic events after spinal surgery: A single institution series of 6869 consecutive patients.
    Cloney MB; Driscoll CB; Yamaguchi JT; Hopkins B; Dahdaleh NS
    Clin Neurol Neurosurg; 2020 Sep; 196():105982. PubMed ID: 32570019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.
    Ageno W; Haas S; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Pieper KS; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    Thromb Haemost; 2019 Feb; 119(2):319-327. PubMed ID: 30593086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
    LaMori JC; Shoheiber O; Mody SH; Bookhart BK
    Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.